A US perspective on newborn screening: a powerful tool for prevention

Figures & data

Table 1. Outcome for conditions nominated for addition to the RUSP [47].

Condition	Date of nomination	Underwent external evidence review	Recommended for addition to the RUSP	Date of addition to the RUSP
Severe combined immunodeficiency	2007	Yes	Yes	2010
Pompe disease	2007	Yes	No
Niemann-Pick disease	2007	No
Fabry disease	2007	No
Krabbe disease	2008	Yes	No
Spinal muscular atrophy	2008	No
Hemoglobin H disease	2009	Yes	No
Neonatal hyperbilirubinemia	2009	Yes	No
Critical congenital heart disease	2009	Yes	Yes	2011
22q11.2 deletion syndrome	2011	No
MPS 1 (α-L-iduronidase deficiency)	2012	Yes
Pompe disease	2012	Yes	Yes*
X-linked adrenoleukodystrophy	2012	No
X-linked adrenoleukodystrophy	2013	Yes^‡

*To be determined by Health and Human Services Secretary.

^‡Under external review.

RUSP: Recommended Uniform Screening Panel.

Available from: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/ [Accessed 1 October 2014]

 Google Scholar